Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 10, 2012 - Issue 1
Submit an article Journal homepage
165
Views
17
CrossRef citations to date
0
Altmetric
Drug Profile

Elvitegravir: a once-daily, boosted, HIV-1 integrase inhibitor

Harry W Lampiris University of California, San Francisco, CA, USA and San Francisco Veterans Affairs Medical Center, 4150 Clement Street, Mail Code 111-W, San Francisco, CA, USA. [email protected]
Pages 13-20 | Published online: 10 Jan 2014

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Stefano Bonora, Andrea Calcagno, Alice Trentalange & Giovanni Di Perri. (2016) Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults. Expert Opinion on Pharmacotherapy 17:3, pages 409-419.
Read now

Articles from other publishers (16)

Andrea R. Thurman, Louise A. Ouattara, Nazita Yousefieh, Peter L. Anderson, Lane R. Bushman, Xi Fang, Homaira Hanif, Meredith Clark, Onkar Singh & Gustavo F. Doncel. (2023) A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Hao-Wei Chu, Bidyadhar Sethy, Pei-Wen Hsieh & Jim-Tong Horng. (2021) Identification of Potential Drug Targets of Broad-Spectrum Inhibitors with a Michael Acceptor Moiety Using Shotgun Proteomics. Viruses 13:9, pages 1756.
Crossref
Rajaiah Alexpandi, Joelma Freire De Mesquita, Shunmugiah Karutha Pandian & Arumugam Veera Ravi. (2020) Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis. Frontiers in Microbiology 11.
Crossref
Minal R. Ghante, Akash C. Masale, Supriya G. Jagtap, Sanjay D. Sawant & Vandana S. Nikam. (2020) SIMPLE, COST EFFECTIVE UV-VIS METHOD FOR ESTIMATION OF ELVITEGRAVIR (EVG) IN PURE AND DOSAGE FORM BY QBD APPROACH AND IN PRESENCE OF MAMMALIAN PLASMA. INDIAN DRUGS 57:01, pages 51-58.
Crossref
Bum Sik Chin, Jin-Hee Lee & Gayeon Kim. (2020) Similar Durability of Two Single Tablet Regimens, Dolutegravir/Abacavir/Lamivudine and Elvitegravir/Cobicistat/Tenofovir/Emtricitabine: Single Center Experience. Journal of Korean Medical Science 35:29.
Crossref
Umesh Panwar, Ishwar Chandra, Chandrabose Selvaraj & Sanjeev K. Singh. (2019) Current Computational Approaches for the Development of Anti-HIV Inhibitors: An Overview. Current Pharmaceutical Design 25:31, pages 3390-3405.
Crossref
Derek E. Murrell, David B. Cluck, Jonathan P. Moorman, Stacy D. Brown, Ke-Sheng Wang, Michelle M. Duffourc & Sam Harirforoosh. (2019) HIV Integrase Inhibitor Pharmacogenetics: An Exploratory Study. Clinical Drug Investigation 39:3, pages 285-299.
Crossref
Muneeb Mohideen, Elias Quijano, Eric Song, Yang Deng, Gauri Panse, Wei Zhang, Meredith R. Clark & W. Mark Saltzman. (2017) Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir. Biomaterials 144, pages 144-154.
Crossref
Mark G.J. de Boer, Guido E.L. van den Berk, Natasja van Holten, Josephine E. Oryszcyn, Willemien Dorama, Daoud ait Moha & Kees Brinkman. (2016) Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice. AIDS 30:18, pages 2831-2834.
Crossref
Nicole L. De La Mata, David A. Cooper, Darren Russell, Don Smith, Ian Woolley, Maree O. Sullivan, Stephen Wright & Matthew Law. (2016) Treatment durability and virological response in treatment-experienced HIV-positive patients on an integrase inhibitor-based regimen: an Australian cohort study. Sexual Health 13:4, pages 335.
Crossref
Tomas Doyle, David T. Dunn, Francesca Ceccherini-Silberstein, Carmen De Mendoza, Frederico Garcia, Erasmus Smit, Esther Fearnhill, Anne-Genevieve Marcelin, Javier Martinez-Picado, Rolf Kaiser & Anna Maria Geretti. (2015) Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades. Journal of Antimicrobial Chemotherapy 70:11, pages 3080-3086.
Crossref
Mitalee Tamhane, Manoj Maniar, Chen Ren, Kenza E. Benzeroual & David R. Taft. (2013) Disposition of ON 01210.Na (Ex-RAD(R)), a Novel Radioprotectant, in the Isolated Perfused Rat Liver: Probing Metabolic Inhibition to Increase Systemic Exposure. Journal of Pharmaceutical Sciences 102:2, pages 732-740.
Crossref
Miłosz Parczewski, Dorota Bander, Anna Urbańska & Anna Boroń-Kaczmarska. (2012) HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland. BMC Infectious Diseases 12:1.
Crossref
Anna Maria Geretti, Daniele Armenia & Francesca Ceccherini-Silberstein. (2012) Emerging patterns and implications of HIV-1 integrase inhibitor resistance. Current Opinion in Infectious Diseases 25:6, pages 677-686.
Crossref
Erik M. van MaarseveenChristin C. RogersJennifer Trofe-ClarkArjan D. van ZuilenTania Mudrikova. (2012) Drug–Drug Interactions Between Antiretroviral and Immunosuppressive Agents in HIV-Infected Patients After Solid Organ Transplantation: A Review. AIDS Patient Care and STDs 26:10, pages 568-581.
Crossref
Liming Hu, Song Yan, Zaigang Luo, Xiao Han, Yujie Wang, Zhanyang Wang & Chengchu Zeng. (2012) Design, Practical Synthesis, and Biological Evaluation of Novel 6-(Pyrazolylmethyl)-4-quinoline-3-carboxylic Acid Derivatives as HIV-1 Integrase Inhibitors. Molecules 17:9, pages 10652-10666.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.